Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of the Costimulatory Molecule B7-H4 in the Decidua and Placental Tissues in Patients with Placental Abruption. | Biomedicines | 2022 | 35453668 | PubTator, text mining | PubMed |
| The genomic landscape of pediatric renal cell carcinomas. | iScience | 2022 | 35445187 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. | Front Immunol | 2022 | 35444654 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy. | EBioMedicine | 2022 | 35439678 | PubTator, text mining | PubMed |
| Amniogenesis occurs in two independent waves in primates. | Cell Stem Cell | 2022 | 35439430 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma. | Ann Transl Med | 2022 | 35434016 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer. | Front Cell Dev Biol | 2022 | 35433686 | PubTator, text mining | PubMed |
| Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation. | Front Oncol | 2022 | 35433415 | PubTator, text mining | PubMed |
| From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. | World J Clin Oncol | 2022 | 35433296 | PubTator, text mining | PubMed |
| Application of High-Throughput Imaging Mass Cytometry Hyperion in Cancer Research. | Front Immunol | 2022 | 35432353 | PubTator, text mining | PubMed |
| Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients. | Front Immunol | 2022 | 35432324 | PubTator, text mining | PubMed |
| The role of epigenetic modifications in Colorectal Cancer Metastasis. | Clin Exp Metastasis | 2022 | 35429301 | PubTator, text mining | PubMed |
| SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. | BMC Cancer | 2022 | 35421944 | PubTator, text mining | PubMed |
| Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response. | Front Immunol | 2022 | 35418980 | PubTator, text mining | PubMed |
| B7-H4 expression is upregulated by PKCδ activation and contributes to PKCδ-induced cell motility in colorectal cancer. | Cancer Cell Int | 2022 | 35410218 | PubTator, text mining | PubMed |
| Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers. | Int J Mol Sci | 2022 | 35409404 | PubTator, text mining | PubMed |
| Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. | Cancers (Basel) | 2022 | 35406529 | PubTator, text mining | PubMed |
| Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes. | Appl Immunohistochem Mol Morphol | 2022 | 35384874 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=45